Aspen Pharmacare (OTCMKTS:APNHY – Get Free Report)’s stock price gapped up before the market opened on Thursday . The stock had previously closed at $7.18, but opened at $7.66. Aspen Pharmacare shares last traded at $7.56, with a volume of 447 shares changing hands.
Aspen Pharmacare Trading Up 6.0%
The company has a quick ratio of 1.18, a current ratio of 2.21 and a debt-to-equity ratio of 0.37. The stock’s fifty day simple moving average is $5.84 and its 200-day simple moving average is $6.00.
Aspen Pharmacare Company Profile
Aspen Pharmacare Holdings Limited is a multinational pharmaceutical company headquartered in Durban, South Africa. Founded in 1997 by Stephen Saad and Gus Attridge, Aspen has grown from a regional generic drug producer into a global specialist in branded and generic medicines. The company is publicly traded on the Johannesburg Stock Exchange and its American depositary receipts trade over‐the‐counter under the symbol APNHY.
Aspen’s core business encompasses the development, manufacture and distribution of a broad portfolio of injectable and oral pharmaceutical products.
See Also
- Five stocks we like better than Aspen Pharmacare
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
- The Crash Has Already Started (Most Just Don’t See It Yet)
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.
